AMCAP Fund - All Holdings | American Funds

GROWTH FUNDS

®

197 Total Holdings:
As of 6/30/19
All Holdings: 1 - 15 of 197
Security Name Asset Type Shares or
Principal Amount
Market Value Percent of
Net Assets
descending arrow
Capital Group Central Cash Fund Short Term 64,579,756 $6,457,329,797.00 9.53%
Netflix, Inc. Equity 5,997,000 $2,202,818,040.00 3.25%
Abbott Laboratories Equity 24,289,454 $2,042,743,081.00 3.01%
Microsoft Corp. Equity 12,849,001 $1,721,252,174.00 2.54%
Facebook, Inc., Class A Equity 8,793,800 $1,697,203,400.00 2.5%
UnitedHealth Group Inc. Equity 6,395,906 $1,560,665,023.00 2.3%
Amazon.com, Inc. Equity 707,700 $1,340,121,951.00 1.98%
EOG Resources, Inc. Equity 14,420,100 $1,343,376,516.00 1.98%
Broadcom Inc. Equity 4,449,848 $1,280,933,245.00 1.89%
Thermo Fisher Scientific Inc. Equity 4,364,610 $1,281,798,665.00 1.89%
Mastercard Inc., Class A Equity 4,061,957 $1,074,509,485.00 1.59%
Concho Resources Inc. Equity 9,568,742 $987,302,800.00 1.46%
Illumina, Inc. Equity 2,663,757 $980,662,140.00 1.45%
Amgen Inc. Equity 4,813,275 $886,990,317.00 1.31%
Worldpay, Inc., Class A Equity 7,088,570 $868,704,254.00 1.28%
All Holdings: 1 - 15 of 197

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.

All Capital Group trademarks mentioned are owned by The Capital Group Companies, Inc., an affiliated company or fund. All other company and product names mentioned are the property of their respective companies.

American Funds Distributors, Inc., member FINRA.

This content, developed by Capital Group, home of American Funds, should not be used as a primary basis for investment decisions and is not intended to serve as impartial investment or fiduciary advice.